港股公告掘金 | 信达生物与武田制药达成全球战略合作及根据一般授权发行股份

智通财经2025-10-22

【重大事项】信达生物(01801)与武田制药达成全球战略合作及根据一般授权发行股份中国联通(00762)拟分拆智网科技至深交所创业板上市老铺黄金(06181)拟折让约4.50%配售371.18万股新H股净筹约27.07亿港元信利国际(00732)拟以公开投标方式收购信利仁寿的共计约11.43%股权轩竹生物-B(02575)：吡洛西利一线治疗HR+/HER2-晚期乳腺癌临床III期研究数据于...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2577961303?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-10-22 23:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577961303","market":"fut","top_or_hot":-1,"title":"港股公告掘金 | 信达生物与武田制药达成全球战略合作及根据一般授权发行股份","media":"智通财经","content":"<div>\n<p>【重大事项】信达生物(01801)与武田制药达成全球战略合作及根据一般授权发行股份中国联通(00762)拟分拆智网科技至深交所创业板上市老铺黄金(06181)拟折让约4.50%配售371.18万股新H股 净筹约27.07亿港元信利国际(00732)拟以公开投标方式收购信利仁寿的共计约11.43%股权轩竹生物-B(02575)：吡洛西利一线治疗HR+/HER2-晚期乳腺癌临床III期研究数据于...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1358440.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股公告掘金 | 信达生物与武田制药达成全球战略合作及根据一般授权发行股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股公告掘金 | 信达生物与武田制药达成全球战略合作及根据一般授权发行股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-22 23:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1358440.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【重大事项】信达生物(01801)与武田制药达成全球战略合作及根据一般授权发行股份中国联通(00762)拟分拆智网科技至深交所创业板上市老铺黄金(06181)拟折让约4.50%配售371.18万股新H股 净筹约27.07亿港元信利国际(00732)拟以公开投标方式收购信利仁寿的共计约11.43%股权轩竹生物-B(02575)：吡洛西利一线治疗HR+/HER2-晚期乳腺癌临床III期研究数据于...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1358440.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1123","symbol_name":"航空公司","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1358440.html","article_id":"2577961303","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577961303","pubTimestamp":1761145247,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【重大事项】信达生物(01801)与武田制药达成全球战略合作及根据一般授权发行股份中国联通(00762)拟分拆智网科技至深交所创业板上市老铺黄金(06181)拟折让约4.50%配售371.18万股新H股 净筹约27.07亿港元信利国际(00732)拟以公开投标方式收购信利仁寿的共计约11.43%股权轩竹生物-B(02575)：吡洛西利一线治疗HR+/HER2-晚期乳腺癌临床III期研究数据于202","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1123":"航空公司","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU0502904849.HKD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (HKD) ACC","BK1227":"服装、服饰与奢侈品","BK1133":"综合电信业务","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A","BK1536":"电信股","BK1589":"北水核心资产","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","00762":"中国联通","BK1506":"5G概念","BK4007":"制药","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","SG9999002463.SGD":"LionGlobal China Growth SGD","LU0455707207.USD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (USD) INC","BK1161":"生物科技","01801":"信达生物","SG9999001051.SGD":"United Asia Fund SGD","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","00293":"国泰航空","LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","BK1561":"航空股","TAK":"武田制药","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","BK1544":"黄金股","BK1583":"高瓴概念","SGXZ90724238.SGD":"UNITED ASIA \"A\" (SGD) INC","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC"},"translate_title":"Hong Kong Stock Announcement Nuggets | Innovent Biologics and Takeda Pharmaceuticals reach global strategic cooperation and issue shares under general mandate","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00762":0.9,"01801":1.5,"00293":0.9,"TAK":1.5},"content_text":"【重大事项】信达生物(01801)与武田制药达成全球战略合作及根据一般授权发行股份中国联通(00762)拟分拆智网科技至深交所创业板上市老铺黄金(06181)拟折让约4.50%配售371.18万股新H股 净筹约27.07亿港元信利国际(00732)拟以公开投标方式收购信利仁寿的共计约11.43%股权轩竹生物-B(02575)：吡洛西利一线治疗HR+/HER2-晚期乳腺癌临床III期研究数据于2025年ESMO公布劲方医药-B(02595)：KRAS G12D抑制剂GFH375联合西妥昔单抗或化疗治疗晚期实体瘤的Ib/II期研究完成首例患者给药威华达控股(00622)拟5.03亿港元出售盛京H股华检医疗(01931)拟将公司英文名称更改为“ETHK Labs Inc.”诺辉健康(06606)上市地位将自10月27日起取消上坤地产(06900)10月27日起被取消上市地位建中建设(00589)10月27日起被取消上市地位【回购/增减持】美的集团(00300)10月22日斥资9999.6万元回购135.84万股A股瑞声科技(02018)10月22日耗资约1190.98万港元回购30万股联易融科技-W(09959)10月22日耗资747.075万港元回购243万股蒙牛乳业(02319)10月22日斥资717.14万港元回购50万股赣锋锂业(01772)副总裁傅利华拟减持公司股份不超过4万股【经营业绩】中国联通(00762)发布前三季度业绩，股东应占盈利200亿元 同比提升5.1%中国中铁(00390)前9个月累计新签合同额15849.2亿元 同比增加3.7%中国交通建设(01800)前三季度新签合同额13,399.70亿元，同比增长4.65%国泰航空(00293)9月载客量同比增加 21%滔搏(06110)公布中期业绩 公司权益持有人应占溢利约7.89亿元 同比减少9.69%上海石油化工股份(00338)发布前三季度业绩，归母净亏损4.32亿元","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2577961303","isCrawlerRequest":true}